(Q40682645)

22 September 2017

title

Insulin therapies - past, present and future (English)

1 reference

22 September 2017

O Pillai

1

1 reference

22 September 2017

R Panchagnula

series ordinal

2

1 reference

22 September 2017

publication date

1 October 2001

1 reference

22 September 2017

1 reference

22 September 2017

volume

6

1 reference

22 September 2017

issue

20

1 reference

22 September 2017

page(s)

1056-1061

1 reference

The new insulins. Their characteristics and clinical indications

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Recent approaches in insulin delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Immunoassay of endogenous plasma insulin in man

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Drug delivery: an odyssey of 100 years

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Drug discovery: a historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Quo vadis, biotech? (Part 1)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Insulin analogues: new agents for improving glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Genomics and medicine. Dissecting human disease in the postgenomic era.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Insulin delivery using pen devices. Simple-to-use tools may help young and old alike

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Pharmacokinetic considerations of new insulin formulations and routes of administration

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

1 reference

7 January 2021

Oral insulin delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Design and in vivo evaluation of an oral delivery system for insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

A new approach to the oral administration of insulin and other peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

The physiologic replacement of insulin. An elusive goal

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Clinical Control of Diabetes by the Artificial Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Implantable insulin pumps

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

A sweeter life for diabetics?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Transdermal iontophoresis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Towards gene therapy of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Extracellular matrix for a rechargeable cell delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Development of engineered pancreatic beta-cell lines for cell therapy of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Glucose-responsive gene delivery in pancreatic Islet cells via recombinant adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Insulin analogs with improved pharmacokinetic profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Microchips as Controlled Drug-Delivery Devices

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

1 reference

7 January 2021

Crystalline and amorphous insulin-zinc compounds with prolonged action

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Chemistry of insulin; determination of the structure of insulin opens the way to greater understanding of life processes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Structure of Rhombohedral 2 Zinc Insulin Crystals

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Expression in Escherichia coli of chemically synthesized genes for human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Lispro insulin: benefits and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901962-6

1 reference

7 January 2021

10.1016/S1359-6446(01)01962-6

Identifiers

DOI

1 reference

22 September 2017

1 reference